The immunodominance of RBD antigen of delta variant as vaccine candidate against SARS-CoV-2 infection. Luo D, Li T, Yang X, Ning N, et al. J Med Virol 2022 Nov 29. doi: 10.1002/jmv.28359.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Luo D, Li T, Yang X, Ning N, et al. The immunodominance of RBD antigen of delta variant as vaccine candidate against SARS-CoV-2 infection. J Med Virol 2022 Nov 29. doi: 10.1002/jmv.28359.
PMID: 36448090